The Checkup by Singlecare

NOVEMBER 6, 2023

Food and Drug Administration (FDA) just approved Wezlana (ustekinumab-auub), a biosimilar for the popular drug Stelara. According to the FDA announcement, the most serious side effect of Wezlana is infection because the prescription affects your immune response.

FDA 110

FDA Immunization 110

The Checkup by Singlecare

FEBRUARY 22, 2024

Food and Drug Administration (FDA) extended its prior approval of Xolair (omalizumab) to treat accidental exposure to food allergens. Xolair is not a new drug; it was originally approved in 2003 for the treatment of moderate to severe persistent allergic asthma in some patients. 16, the U.S. What is Xolair? RN, the CEO of FARE.

FDA 103

FDA Immunization 103

Pharmaceutical Technology

APRIL 11, 2023

The US Food and Drug Administration (FDA) has granted final approval to India-based Zydus Lifesciences ‘ 500mg azithromycin tablets for the treatment of bacterial infections. Zydus, which currently has 360 approvals, has filed abbreviated new drug applications for more than 440 drugs since 2003-04.

FDA 52

FDA Immunization Vaccines 52

The Checkup by Singlecare

OCTOBER 20, 2023

Inflammation is a natural response by the body’s immune system to protect itself from harmful bacteria or during an injury. Traditional medicine practitioners believe that shilajit eases these symptoms because of its high fulvic acid and mineral content, which helps stimulate the immune system and promotes energy production in the body.

Immunization 105

Immunization FDA 105

European Pharmaceutical Review

SEPTEMBER 22, 2023

Limitations of monoclonal antibody therapies Regulatory approvals from the US Food and Drug Administration (FDA) for aducanumab and lecanemab – and likely very soon for donanemab also – opened a route for different therapeutic modalities and other relevant disease targets, such as tau.

Immunization 78

Immunization Vaccines Communication Labelling 78

European Pharmaceutical Review

OCTOBER 19, 2023

Granzyme B is an enzyme released by activated immune cells and using this as a in vivo imaging biomarker has great potential to monitor immune cell activation in a variety of inflammatory diseases, autoimmune diseases, cancer and infections. Barrett at the Center for Gamma Ray Imaging.

Chemotherapy 90

Chemotherapy Compounding Immunization FDA 90

PharmaShots

JUNE 28, 2023

Today's FDA approval shows that innovation doesn't stop with a drug's first market approval, and further reflects Amgen's commitment to continually unlock and expand the therapeutic potential of our medicines in the hopes of filling unmet patient needs. Below are some of the KOL reviews for Enbrel.

Insurance Coverage 40

Insurance Coverage Dosage Compounding Insurance 40